Tag Archives: vivo gene editing

Bayer and Acuitas Therapeutics Join Forces for Targeted Gene Editing Delivery

Not intended for U.S. and UK Media (IN BRIEF) Bayer AG has partnered with Acuitas Therapeutics, Inc. to enhance its gene therapy portfolio. Acuitas’ lipid nanoparticle (LNP) delivery technology will enable targeted and efficient delivery of gene editing RNA components … Read the full press release